English syllables. 2014.

Look at other dictionaries:

  • Phenoxybenzamine — Systematic (IUPAC) name (RS) N benzyl N (2 chloroethyl) 1 phenoxypropan 2 amine Clinical data Trade names …   Wikipedia

  • phenoxybenzamine — /fi nok see ben zeuh meen /, n. Pharm. an alpha blocker, C18H22ClNO, used to dilate vascular peripheral blood vessels in the treatment of Raynaud s disease and in pheochromocytoma. [PHEN + OXY 2 + BENZAMINE] * * * …   Universalium

  • phenoxybenzamine — noun an alpha blocker and vasodilator …   Wiktionary

  • phenoxybenzamine — phe·noxy·ben·za·mine ben zə .mēn n a drug that blocks the activity of alpha receptors and is used in the form of its hydrochloride C18H22ClNO·HCl esp. in the treatment of hypertension and sweating due to pheochromocytoma * * * n. a drug that… …   Medical dictionary

  • phenoxybenzamine — n. a drug that dilates blood vessels (see alpha blocker). It is used to reduce high blood pressure in patients with phaeochromocytoma. It is administered by mouth or injection and may cause dizziness and fast heartbeat. Trade names: Dibenyline …   The new mediacal dictionary

  • phenoxybenzamine — fə̇¦näksē¦benzəˌmēn noun Etymology: International Scientific Vocabulary phen + oxy (II) + benz + amine : a drug C18H22ClNO that blocks the activity of alpha receptors and is used in the form of its hydrochloride especially to produce peripheral… …   Useful english dictionary

  • phenoxybenzamine hydrochloride — A potent nonselective adrenergic (α receptor) blocking agent of the β haloalkylamines; blocks the excitatory response of smooth muscle and exocrine glands to epinephrine; used in the treatment of peripheral …   Medical dictionary

  • Norepinephrine — Norepinephrine[1] …   Wikipedia

  • Phentolamine — Systematic (IUPAC) name …   Wikipedia

  • Tolazoline — Systematic (IUPAC) name 2 benzyl 4,5 dihydro 1H imidazole Clinical data AHFS/ …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.